Navidea to Present at Upcoming Investor Conference
January 06 2017 - 4:15PM
Business Wire
Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB) today announced
that management will present at an upcoming investor conference. An
audio webcast of the presentation will be available live at the URL
links noted below. An archived version of the webcast will be
available approximately two hours following the presentations and
can be accessed within the Investors' section of the Navidea
website http://ir.navidea.com.
2017 Biotech Showcase Conference in San Francisco on
Monday, January 9, 2017 at 4:30 p.m., Pacific Time (7:30 p.m. ET).
Webcast Link:
https://event.webcasts.com/starthere.jsp?ei=1131242
About Navidea
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a
biopharmaceutical company focused on the development and
commercialization of precision immunodiagnostic agents and
immunotherapeutics. Navidea is developing multiple
precision-targeted products and platforms including Manocept™ and
NAV4694 to help identify the sites and pathways of undetected
disease and enable better diagnostic accuracy, clinical
decision-making, targeted treatment and, ultimately, patient care.
Lymphoseek® (technetium Tc 99m tilmanocept) injection, Navidea’s
first commercial product from the Manocept platform, was approved
by the FDA in March 2013 and in Europe in November 2014. The
development activities of the Manocept immunotherapeutic platform
will be conducted by Navidea in conjunction with its subsidiary,
Macrophage Therapeutics. Navidea’s strategy is to deliver superior
growth and shareholder return by bringing to market novel products
and advancing the Company’s pipeline through global partnering and
commercialization efforts. For more information, please visit
www.navidea.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170106005718/en/
Navidea BiopharmaceuticalsInvestors &
MediaJed Latkin, 614-973-7490COO &
CFOjlatkin@navidea.com
Navidea Biopharmaceuticals (AMEX:NAVB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Navidea Biopharmaceuticals (AMEX:NAVB)
Historical Stock Chart
From Apr 2023 to Apr 2024